Medicus Pharma Cash Flow Statement (2023-2025) | MDCX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -0.23M-3.84M-1.71M-3.55M-2.33M-3.59M-5.10M-6.02M-15.00-7.79M
Depreciation and Depletion (Quarter) 0.03M
Share-based Compensation (Quarter) 0.04M0.59M0.09M0.11M0.12M0.85M0.43M
Gains from Investment Securities (Quarter) 0.36M
Cash from Operations (Quarter) -4.93M-1.18M-2.78M-3.94M-5.47M-6.76M-6.61M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.01M-0.03M0.09M0.34M
Depreciation & Amortization (CF) (Quarter) 0.03M
Change in Working Capital
Change in Account Payables (Quarter) 0.05M-0.08M0.27M0.57M-0.02M0.00M0.02M-0.03M
Change in Accured Expenses (Quarter) -0.01M0.22M0.02M0.12M0.30M0.77M-0.95M-0.55M
Financing Activities
Other financing activities (Quarter) 0.03M-0.19M0.29M0.07M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 5.17M-5.17M-4.50M11.87M
Long-Term Debt Repayments (Quarter) 1.75M
Change in Capital Stock
Shares Issued (Quarter) 5.47M-2.77M3.75M5.15M
Misc.
Cash from Financing Activities (Quarter) 10.64M3.76M11.16M10.37M6.65M
Exchange Rate Effect (Quarter) -0.00M
Change in Cash (Quarter) -1.18M7.87M-0.18M5.69M-1.01M0.04M
Free Cash Flow (Quarter) -4.93M-1.18M-2.78M-3.94M-5.47M-6.76M-6.61M
Net Cash Flow (Quarter) -4.93M-1.18M7.87M-0.18M5.69M3.61M0.04M